M&A Deal Summary

Novadaq Technologies Acquires Xillix Technologies

On April 23, 2007, Novadaq Technologies acquired medical products company Xillix Technologies for 3M CAD

Acquisition Highlights
  • This is Novadaq Technologies’ 1st transaction in the Medical Products sector.
  • This is Novadaq Technologies’ 2nd largest (disclosed) transaction.
  • This is Novadaq Technologies’ 1st transaction in Canada.
  • This is Novadaq Technologies’ 1st transaction in British Columbia.

M&A Deal Summary
Date 2007-04-23
Target Xillix Technologies
Sector Medical Products
Buyer(s) Novadaq Technologies
Deal Type Add-on Acquisition
Deal Value 3M CAD

Target

Xillix Technologies

Richmond, British Columbia, Canada
Xillix Technologies Corp. is a manufacturer of medical device company.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Novadaq Technologies

Mississauga, Ontario, Canada
Category Company
Founded 2000
Sector Medical Products
DESCRIPTION

Novadaq Technologies is a developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures. Novadaq Technologies was founded in 2000 and is based in Mississauga, Ontario.

DEAL STATS #
Overall 2 of 5
Sector (Medical Products) 1 of 4
Type (Add-on Acquisition) 1 of 2
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2007) 2 of 2
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-03-21 Edwards Lifesciences - TMR Heart Laser Distribution Rights

Irvine, California, United States

Edwards Lifesciences Corp. - TMR Heart Laser Distribution Rights distribution rights supports Edwards' strategy to focus on proprietary, physician-preference products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-02 Digirad - Imaging Lymph Nodes and Surgical Margin Assets

Suwanee, Georgia, United States

Digirad Corp. - Imaging Lymph Nodes and Surgical Margin Assets includes five patent applications, and Novadaq has been granted an exclusive license to 13 patents already issued for using the technology perioperatively.

Buy $2M
Mergr

Product

Company

Legal